Il 6 Pathway | List of Frontiers open access articles

Original Research

Published on 31 May 2024

Expression and clinical significance of interleukin-6 pathway in cholangiocarcinoma

in Cancer Immunity and Immunotherapy

Dongqing Gu
Xin Zhao
Jing Song
Jianmei Xiao
Leida Zhang
Guohong Deng
Dajiang Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1374967

4,589 views
3 citations

Review

Published on 15 Mar 2022

IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment

in Molecular and Cellular Oncology

Sara G. Manore
Daniel L. Doheny
Grace L. Wong
Hui-Wen Lo

Frontiers in Oncology

doi 10.3389/fonc.2022.866014

34,599 views
243 citations

Original Research

Published on 05 Jun 2023

Downregulation of interleukin 6 signaling might reduce the risk of periodontitis: a drug target Mendelian randomization study

in Inflammation

Michael Nolde
Zoheir Alayash
Stefan Lars Reckelkamm
Thomas Kocher
Benjamin Ehmke
Birte Holtfreter
Hansjörg Baurecht
Marios K. Georgakis
Sebastian-Edgar Baumeister

Frontiers in Immunology

doi 10.3389/fimmu.2023.1160148

10,565 views
25 citations

Case Report

Published on 12 Feb 2026

Prompt clinical and electrophysiological remission of refractory peripheral neuropathy in long-standing rheumatoid arthritis with tocilizumab: a case report

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Hai Huang
Xuexian Zhong
Shan Kuang
Jinhui Tan
Linghua Tan
Bo Li

Frontiers in Immunology

doi 10.3389/fimmu.2026.1770170

159 views

Original Research

Published on 31 Oct 2019

A Dynamic Transcriptional Analysis Reveals IL-6 Axis as a Prominent Mediator of Surgical Acute Response in Non-ischemic Mouse Heart

in Systems Biology Archive

Sally Badawi
Alexandre Paccalet
Zeina Harhous
Bruno Pillot
Lionel Augeul
Fabien Van Coppenolle
Joel Lachuer
Mazen Kurdi
Claire Crola Da Silva
Michel Ovize

Frontiers in Physiology

doi 10.3389/fphys.2019.01370

7,624 views
2 citations

Brief Research Report

Published on 10 Dec 2020

IL-6 but Not TNFα Levels Are Associated With Time to Pregnancy in Female Rheumatoid Arthritis Patients With a Wish to Conceive

in Obstetric and Pediatric Pharmacology

Margot Bongenaar
Hieronymus T. W. Smeele
Erik Lubberts
Radboud J. E. M. Dolhain

Frontiers in Pharmacology

doi 10.3389/fphar.2020.604866

3,973 views
8 citations

Original Research

Published on 13 Aug 2025

Preexisting ulcerative colitis increases the risk of immune-related colitis and predicts divergent survival outcomes in gastrointestinal cancer patients treated with immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Shuo Xu
Lu Chen
Kaixuan Liu
Hui Tao
Zhengzheng Ji
Jiamin Wu
Yuanyi Zhao
Qiankun Zhou
Liuying Li
Hanlong Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1627680

2,263 views

Articles

Expression and clinical significance of interleukin-6 pathway in cholangiocarcinoma

IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment

Downregulation of interleukin 6 signaling might reduce the risk of periodontitis: a drug target Mendelian randomization study

Prompt clinical and electrophysiological remission of refractory peripheral neuropathy in long-standing rheumatoid arthritis with tocilizumab: a case report

A Dynamic Transcriptional Analysis Reveals IL-6 Axis as a Prominent Mediator of Surgical Acute Response in Non-ischemic Mouse Heart

IL-6 but Not TNFα Levels Are Associated With Time to Pregnancy in Female Rheumatoid Arthritis Patients With a Wish to Conceive

Preexisting ulcerative colitis increases the risk of immune-related colitis and predicts divergent survival outcomes in gastrointestinal cancer patients treated with immune checkpoint inhibitors